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Abstract
Research shows that married cancer patients have lower mortality than unmarried patients
but few data exist for breast cancer. We assessed total mortality associated with marital
status, with attention to differences by race/ethnicity, tumor subtype, and neighborhood
socioeconomic status (nSES). We included, from the population-based California Cancer
Registry, women ages 18 and older with invasive breast cancer diagnosed between 2005
and 2012 with follow-up through December 2013. We estimated mortality rate ratios (MRR)
and 95% confidence intervals (CI) for total mortality by nSES, race/ethnicity, and tumor sub-
type. Among 145,564 breast cancer cases, 42.7% were unmarried at the time of diagnosis.
In multivariable-adjusted models, the MRR (95% CI) for unmarried compared to married
women was 1.28 (1.24–1.32) for total mortality. Significant interactions were observed by
race/ethnicity (P<0.001), tumor subtype (P<0.001), and nSES (P = 0.009). Higher MRRs
were observed for non-Hispanic whites and Asians/Pacific Islanders than for blacks or His-
panics, and for HR+/HER2+ tumors than other subtypes. Assessment of interactive effect
between marital status and nSES showed that unmarried women living in low SES neigh-
borhoods had a higher risk of dying compared with married women in high SES neighbor-
hoods (MRR = 1.60; 95% CI: 1.53–1.67). Unmarried breast cancer patients have higher
total mortality than married patients; the association varies by race/ethnicity, tumor subtype,
and nSES. Unmarried status should be further evaluated as a breast cancer prognostic fac-
tor. Identification of underlying causes of the marital status associations is needed to design
interventions that could improve survival for unmarried breast cancer patients.
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Introduction
A growing body of evidence shows that mortality following a cancer diagnosis is higher in
unmarried than married patients [1–4]. However, studies on the association specific to breast
cancer are limited [5, 6], despite this being the most common cancer in women. Some pub-
lished reports included marital status as a covariate in multivariable analyses [7–9], but, to our
knowledge, a focused examination of the specific effect of marital status on breast cancer sur-
vival in different racial/ethnic populations or by tumor subtype has not been reported.
A population-based study published in 2005 [6] showed that compared to married breast
cancer patients, unmarried women were more likely to be diagnosed with later stage disease
and to die of breast cancer, and were less likely to receive definitive treatment, even after con-
trolling for stage, treatment, socioeconomic factors, and comorbidities. A more recent study
conducted in a safety net hospital reported an over 2-fold increase in breast cancer mortality in
single versus married breast cancer patients [5]. However, none of these studies examined
whether the marital status effects on survival differ across patient subgroups or tumor subtypes.
We recently reported significant heterogeneity in the association between marital status
and survival across racial/ethnic and nativity groups [4]; however, this research was not spe-
cific to breast cancer. Understanding the extent to which marital status impacts survival after
breast cancer diagnosis across sociodemographic groups is needed to help target interventions.
However, there are limited data regarding the extent to which marriage benefits survival in
these groups. Importantly, since breast cancer is recognized to be a heterogeneous disease,
data are needed on how the marital status associations with mortality differ by tumor subtype.
Using data from the population-based California Cancer Registry (CCR), we conducted a
comprehensive examination of the association of marital status and total mortality among
women diagnosed with invasive breast cancer. Specifically, we assessed main effects of being
unmarried and total mortality and whether the association varied by race/ethnicity, neighbor-
hood socioeconomic status (nSES), and tumor subtype.
Materials and methods
Study population
We obtained from the CCR information on 152,380 female California residents age 18 and
above who were diagnosed with a first primary invasive breast cancer [International Classifica-
tion of Disease for Oncology, 3rd Edition, (ICD-O-3) site codes C50.0–50.9, with the following
ICD-O-3 coded histological subtypes of breast carcinoma or adenocarcinoma: 8000, 8001,
8010, 8020, 8022, 8050, 8140, 8201, 8211, 8230, 8255, 8260, 8401, 8453, 8480, 8481, 8500–8530,
and 8575] during the period January 1, 2005 through December 31, 2012. We excluded pa-
tients who had no information on marital status at diagnosis (n = 6,179) and who were diag-
nosed by mammography/xerography (n = 70) or death certificate/autopsy (n = 567), and
thereby included 145,564 patients in the final analysis.
CCR data on race, ethnicity, birthplace, and marital status were abstracted from medical
records of reporting facilities and are based primarily on self-report. We also obtained from
the CCR data on address at diagnosis (geocoded to census block group), American Joint Com-
mittee on Cancer (AJCC) stage, tumor size, lymph node involvement, grade, primary source
of payment at the time of initial diagnosis and/or treatment, as well as treatment modalities
(surgery, type of surgery, chemotherapy, and radiation therapy).
Birthplace is coded as US- or foreign-born. As previous research shows that birthplace is
differentially missing in the cancer registry data between US- and foreign-born Hispanics and
Asians/Pacific Islanders (APIs) [10, 11], we imputed nativity using patients’ social security
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numbers (SSN) for the 33% of Hispanics and 30% of APIs with missing registry birthplace. This
validated imputation method assigns a foreign birthplace to Hispanic patients who received
their SSNs after the age of 24 and to APIs after the age of 20 [12, 13]. Patient residential address
at diagnosis was geocoded and assigned to a census block group, then linked to nSES indices
developed through principal components analyses. The two indices, based on Census 2000 data
(for cases diagnosed in 2005) and American Community Survey 2007–2011 data (for cases diag-
nosed 2006–2012), were developed separately but included the same components: education,
occupation, employment, household income, poverty, rent and house values. [14, 15]. Vital sta-
tus as of December 31, 2013 was obtained through linkages to various vital records databases.
The CCR has collected information on the expression of ER and PR since 1990 and of
HER2 since 1999 [16]. Data completeness for HER2 is over 80% since 2005. Each marker was
coded as positive, negative, borderline, not tested/recorded, or unknown, based on the results
of the test performed at the reporting facility. We classified breast cancers into four mutually
exclusive subtypes: HR+/HER2- was defined as ER and/or PR positive and HER2 negative; HR
+/HER2+ as ER and/or PR positive and HER2 positive; HR-/HER2+ as ER and PR negative
and HER2 positive; and triple-negative breast cancer as ER, PR, and HER2 negative [16–20].
The study was approved by the institutional review boards at each institution; informed con-
sent was waived as we analyzed de-identified data.
Statistical analysis
We used multivariable-adjusted Cox proportional hazards regression models to estimate haz-
ard rate ratios (MRR) [21] and 95% confidence intervals (CI) [22] to evaluate differences in
total mortality between married and unmarried (never married, separated, divorced, and wid-
owed) breast cancer patients. The proportional hazards assumption was assessed for marital
status and for each covariate by examining the correlation between weighted Schoenfeld resid-
uals and logarithmically transformed survival time; no significant violations of the assumption
were observed, except for stage. Thus, stage was included as a stratifying variable in all Cox
regression models, allowing the baseline hazard to vary by stage. The models were adjusted
for age, race/ethnicity, tumor subtype, treatment, lymph node involvement, tumor size, grade,
histology, insurance status, and nSES. In our prior work, we found evidence of interaction
between marital status and nSES; thus, statistical significance of multiplicative interaction
effect of marital status and nSES was estimated with the Wald test by including a cross-product
term in the Cox models. We also conducted separate analyses by race/ethnicity, tumor sub-
type, nSES, nativity among Hispanics and APIs, and for the six largest API ethnic groups:
Chinese, Japanese, Filipino, Korean, South Asian, and Vietnamese. Cox regression and the
Kaplan-Meier method was used to test statistical differences in overall survival by both marital
status and nSES. All Cox regression models were adjusted for clustering by census block
group. All statistical tests were carried out using SAS software version 9.3 (SAS Institute, Cary,
North Carolina). All P values reported were two-sided, and those that were<0.05 were consid-
ered to be statistically significant.
Results
Characteristics of study population
Among the 145,564 breast cancer patients included in the analyses, 22,610 deaths from any
cause occurred during a total of 620,692 person-years of follow-up. At the time of diagnosis,
the percent of married, single/separated/divorced, and widowed women was 57.3%, 28.5%,
and 14.2%, respectively. Table 1 shows that widowed women were more likely to be older and
to be non-Hispanic white (NHW), and less likely to be uninsured than married or single
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No. (%) No. (%) No. (%) No. (%)
Sociodemographic Characteristics
Age, years
<35 3108 (2.1) 1665 (2.0) 1429 (3.4) 14 (0.1)
35–49 32321 (22.2) 21433 (25.7) 10512 (25.3) 376 (1.8)
50–59 37273 (25.6) 23943 (28.7) 11892 (28.6) 1438 (7.0)
60–64 18697 (12.8) 11408 (13.7) 5742 (13.8) 1547 (7.5)
65–69 16677 (11.5) 9531 (11.4) 4646 (11.2) 2500 (12.1)
70–74 12682 (8.7) 6677 (8.0) 2981 (7.2) 3024 (14.6)
75 24806 (17.0) 8726 (10.5) 4319 (10.4) 11761 (56.9)
Race/ethnicity
Non-Hispanic white 90349 (62.1) 51715 (62.0) 24401 (58.8) 14233 (68.9)
Black 9324 (6.4) 3309 (4.0) 4627 (11.1) 1388 (6.7)
Hispanic 26103 (17.9) 15140 (18.2) 8108 (19.5) 2855 (13.8)
Asian/Pacific Islander 18374 (12.6) 12478 (15.0) 3896 (9.4) 2000 (9.7)
Other/unknown 1414 (1.0) 741 (0.9) 489 (1.2) 184 (0.9)
Neighborhood (block group) statewide SES quintile
1st (lowest) 18450 (12.7) 8686 (10.4) 6815 (16.4) 2949 (14.3)
2nd 25289 (17.4) 13016 (15.6) 8106 (19.5) 4167 (20.2)
3rd 29720 (20.4) 16423 (19.7) 8814 (21.2) 4483 (21.7)
4th 34088 (23.4) 19988 (24.0) 9398 (22.6) 4702 (22.8)
5th (highest) 38017 (26.1) 25270 (30.3) 8388 (20.2) 4359 (21.1)
Insurance status
No insurance 24509 (16.8) 14679 (17.6) 7476 (18.0) 2354 (11.4)
Private 67632 (46.5) 43916 (52.7) 18306 (44.1) 5410 (26.2)
Medicare or Medicare+Private 18742 (12.9) 9324 (11.2) 3715 (8.9) 5703 (27.6)
Any Public/Medicaid/Military 30452 (20.9) 13063 (15.7) 10907 (26.3) 6482 (31.4)
Unknown 4229 (2.9) 2401 (2.9) 1117 (2.7) 711 (3.4)
Clinical Characteristics
AJCC Stage
I 66046 (45.4) 39638 (47.5) 17082 (41.1) 9326 (45.1)
II 48760 (33.5) 28144 (33.8) 14194 (34.2) 6422 (31.1)
III 17754 (12.2) 9756 (11.7) 5711 (13.8) 2287 (11.1)
IV 6982 (4.8) 3084 (3.7) 2729 (6.6) 1169 (5.7)
Unknown 6022 (4.1) 2761 (3.3) 1805 (4.3) 1456 (7.0)
Molecular subtype
HR+/HER2- 87989 (60.4) 50813 (60.9) 24510 (59.0) 12666 (61.3)
HR+/HER2+ 14538 (10.0) 8573 (10.3) 4379 (10.5) 1586 (7.7)
HR-/HER2+ 7274 (5.0) 4329 (5.2) 2116 (5.1) 829 (4.0)
Triple negative 15106 (10.4) 8705 (10.4) 4604 (11.1) 1797 (8.7)
Unclassified 20657 (14.2) 10963 (13.1) 5912 (14.2) 3782 (18.3)
Lymph node involvement
Negative 92823 (63.8) 53962 (64.7) 25195 (60.7) 13666 (66.1)
Positive 48757 (33.5) 27961 (33.5) 14966 (36.0) 5830 (28.2)
Unknown 3984 (2.7) 1460 (1.8) 1360 (3.3) 1164 (5.6)
(Continued )
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patients. Married women were less likely to reside in low SES neighborhoods and more likely
to have private insurance than unmarried women. In regard to tumor subtype, widowed
patients had a lower proportion of HER2+ and triple negative tumors than other women. Wid-
owed women were less likely to undergo surgery and to have chemotherapy or radiation ther-
apy than other women.
Marital status and mortality
After multivariable adjustment, total mortality was 28% higher in unmarried compared to











No. (%) No. (%) No. (%) No. (%)
Tumor Size (cm)
0.10 < tumor0.50 9459 (6.5) 5863 (7.0) 2444 (5.9) 1152 (5.6)
0.50 <tumor 1.00 22449 (15.4) 13550 (16.3) 5620 (13.5) 3279 (15.9)
1.00 <tumor 2.00 48621 (33.4) 28997 (34.8) 13043 (31.4) 6581 (31.9)
2.00 <tumor 5.00 45579 (31.3) 25372 (30.4) 13711 (33.0) 6496 (31.4)
>5.00 11006 (7.6) 5474 (6.6) 3984 (9.6) 1548 (7.5)
Microinvasion 1546 (1.1) 962 (1.2) 414 (1.0) 170 (0.8)
Diffused 757 (0.5) 364 (0.4) 300 (0.7) 93 (0.5)
Unknown 6147 (4.2) 2801 (3.4) 2005 (4.8) 1341 (6.5)
Grade
Grade I 30988 (21.3) 18109 (21.7) 8218 (19.8) 4661 (22.6)
Grade II 58240 (40.0) 33593 (40.3) 16211 (39.0) 8436 (40.8)
Grade III/IV 46587 (32.0) 26937 (32.3) 14123 (34.0) 5527 (26.8)
Unknown 9749 (6.7) 4744 (5.7) 2969 (7.2) 2036 (9.9)
Histology
Ductal 111557 (76.6) 64600 (77.5) 32104 (77.3) 14853 (71.9)
Lobular 23418 (16.1) 13620 (16.3) 6262 (15.1) 3536 (17.1)
Other 10589 (7.3) 5163 (6.2) 3155 (7.6) 2271 (11.0)
Treatment
Surgery
No surgery 10368 (7.1) 4161 (5.0) 3783 (9.1) 2424 (11.7)
Breast conserving surgery 78579 (54.0) 46247 (55.5) 21609 (52.0) 10723 (51.9)
Mastectomy 56339 (38.7) 32845 (39.4) 16053 (38.7) 7441 (36.0)
Other/unknown 278 (0.2) 130 (0.2) 76 (0.2) 72 (0.3)
Chemotherapy
No 83953 (57.7) 45097 (54.1) 22580 (54.4) 16276 (78.8)
Yes 59274 (40.7) 36972 (44.3) 18265 (44.0) 4037 (19.5)
Unknown 2337 (1.6) 1314 (1.6) 676 (1.6) 347 (1.7)
Radiation therapy
No 76327 (52.4) 41365 (49.6) 22165 (53.4) 12797 (61.9)
Yes 69109 (47.5) 41978 (50.3) 19330 (46.6) 7801 (37.8)
Unknown 128 (0.1) 40 (0.0) 26 (0.1) 62 (0.3)
Abbreviations: SES = socioeconomic status; AJCC = American Joint Committee on Cancer; HR = hormone receptor; HER2 = human epidermal receptor 2
https://doi.org/10.1371/journal.pone.0175515.t001
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widowed (MRR = 1.35; 95% CI, 1.30–1.41) than single/separated/divorced women (MRR =
1.24; 95% CI, 1.20–1.28), based on non-overlapping CIs.
We next assessed whether there was variation in the MRRs for marital status and mortality
by race/ethnicity, nativity (among Hispanics and APIs), nSES, or tumor subtype (Table 3).
Significant variation by race/ethnicity was shown (P-heterogeneity <0.0001), albeit the magni-
tude of the differences was modest. Among API ethnic groups, we noted significant associa-
tions for total mortality for Filipinos and other Asians, but numbers of events were limited in
other ethnic groups. Assessing differences by nativity, no significant differences were shown
among APIs, whereas significant variation was observed for Hispanics. The marital status-
mortality associations were higher in US-born than foreign-born Hispanics (P-heterogene-
ity = 0.01) and significant variation by nSES was shown (P-heterogeneity = 0.009). Differences
across tumor subtype for the marital status and mortality association were also evident, with
higher MRRs observed for HR+/HER2- tumors (MRR = 1.32; 95% CI: 1.26–1.37) and lower
for triple negative tumors (MRR = 1.16; 95% CI: 1.08–1.25). In all analyses performed, results
for breast cancer-specific mortality were similar to those observed for all-cause mortality (data
not shown). Also, since the proportion of individuals living with an unmarried partner in the
U.S. has increased over time [23] and we are lacking these data in the registry, we restricted
analyses to women <64 years of age, in whom cohabitation might be higher than in older
patients. Results show no material differences in the MRRs as compared to the total population
(data not shown).
Lastly, we assessed mortality and the interactive effects of marital status and nSES. As
shown in Fig 1, survival was highest among married women who resided in high SES neighbor-
hoods and lowest among unmarried women in low SES neighborhoods. When we conducted
multivariable analyses, a similar pattern emerged (Fig 2 and S1 Table). Compared to married
women who resided in high SES neighborhoods, patients with all other combinations of marital
status (married/unmarried) and SES (low/high) had higher risk of total mortality. In all women,
the strongest association was shown for unmarried patients living in low SES neighborhoods
(MRR = 1.60; 95% CI, 1.53–1.67), which was also evident when we stratified by tumor subtype.
The largest mortality difference by SES/marital status group was seen for women with HR
+/HER2- and the smallest was observed for patients with triple negative tumors (Fig 2).
Table 2. Adjusted mortality rate ratio (MRR) and 95% confidence intervals (CI) for total cancer mortal-
ity associated with marital status, California, 2005–2012.
Total mortality
No. of deaths MRRa (95%CI)
Marital status at diagnosis
Married 9304 1.00 (Reference)
All unmarried 13306 1.28 (1.24–1.32)
Single/Separated/Divorced 6941 1.24 (1.20–1.28)
Widowed 6365 1.35 (1.30–1.41)
aEstimated from Cox proportional hazard models, stratified by stage (AJCC stage I-IV or unknown) and
adjusted for: age (continuous); race/ethnicity (NHW, non-Hispanic white, black, Hispanic, Asian/Pacific
Islander, other/unknown); tumor subtype HR+/HER2-, HR+/HER2+, HR-/HER2, triple negative, and
unclassified); first course of treatment (Y/N for surgery, radiation, hormone therapy); lymph node
involvement (negative, positive, unknown); tumor size (continuous); grade (I, II, II/IV, unknown); histology
(ductal, lobular, other); insurance status (no insurance, private insurance only, Medicare only/Medicare
+ private insurance, any public/Medicaid/military insurance, unknown); and neighborhood socioeconomic
status (quintiles).
https://doi.org/10.1371/journal.pone.0175515.t002
Marital status and breast cancer survival
PLOS ONE | https://doi.org/10.1371/journal.pone.0175515 May 5, 2017 6 / 14
Table 3. Adjusted mortality rate ratios (MRR) and 95% confidence intervals (CIs) for total mortality associated with unmarried vs. married patients,
by race/ethnicity, tumor subtype, neighborhood socioeconomic status (SES), nativity, and Asian/Pacific Islander (API) subgroups, California,
2005–2012.
Total mortality
No. of deaths Unmarried No. of deaths Married MRRa (95%CI)
Unmarried vs. Married
By Race/ethnicity
Non-Hispanic white 8761 5858 1.31 (1.26–1.36)
Black 1599 614 1.17 (1.05–1.30)
Hispanic 1943 1750 1.15 (1.07–1.24)
Asian/Pacific Islander 894 1006 1.29 (1.16–1.43)
Other/unknown 109 76 1.06 (0.74–1.53)
P-heterogeneityb <0.001
Among APIs by ethnic group
Chinese 167 227 1.21 (0.95–1.54)
Japanese 125 92 1.33 (0.96–1.83)
Filipino 305 321 1.24 (1.03–1.50)
Other Asian 138 135 1.35 (1.02–1.79)
Korean 52 68 1.38 (0.89–2.15)
South Asian 47 84 0.84 (0.53–1.33)
Vietnamese 60 79 1.03 (0.68–1.56)
P-heterogeneityb 0.6183
Among Hispanics by nativity
US-born 948 727 1.23 (1.10–1.37)
Foreign-born 995 1023 1.07 (0.97–1.18)
P-heterogeneity b 0.010
Among APIs by nativity
US-born 168 128 1.62 (1.25–2.11)
Foreign-born 722 876 1.25 (1.12–1.41)
P-heterogeneityb 0.425
By Neighborhood SES
1st (lowest) 2526 1357 1.22 (1.13–1.32)
2nd 2918 1804 1.26 (1.18–1.35)
3rd 2857 2009 1.33 (1.24–1.42)
4th 2751 2068 1.22 (1.14–1.30)
5th (highest) 2254 2066 1.32 (1.24–1.42)
P-heterogeneity b 0.009
By Tumor Subtype
HR+/HER2- 5939 4102 1.32 (1.26–1.37)
HR+/HER2+ 1157 899 1.18 (1.07–1.30)
HR-/HER2+ 779 705 1.21 (1.07–1.35)
Triple negative 1961 1803 1.16 (1.08–1.25)
Unclassified 3470 1795 1.35 (1.25–1.46)
P-heterogeneityb <0.0001
aEstimated from Cox proportional hazard models, stratified by stage (AJCC stage I-IV or unknown) and adjusted for: age continuous); race/ethnicity (NHW,
non-Hispanic white, black, Hispanic, Asian/Pacific Islander, other/unknown); tumor subtype HR+/HER2-, HR+/HER2+, HR-/HER2, triple negative, and
unclassified); first course of treatment (Y/N for surgery, radiation, hormone therapy); lymph node involvement (negative, positive, unknown); tumor size
(continuous); grade (I, II, II/IV, unknown); histology (ductal, lobular, other); insurance status (no insurance, private insurance only, Medicare only/Medicare
+ private insurance, any public/Medicaid/military insurance, unknown); and neighborhood socioeconomic status (quintiles).
bLikelihood ratio test for interaction computed based on cross-product terms.
https://doi.org/10.1371/journal.pone.0175515.t003
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Discussion
Results of our population-based study show that breast cancer patients who were unmarried at
diagnosis had a significantly higher risk of dying of all causes compared with those who were
married. Additionally, larger associations among NHW and API women, US-born Hispanics
and APIs, and patients diagnosed with HR+/HER2- tumors were observed.
Although there is a growing body of evidence on the adverse effects of being unmarried
compared to being married on cancer mortality [1, 3, 4, 24–26], data specific to breast cancer
Fig 1. Kaplan-Meier curve of all-cause survival by marital status and neighborhood SES, California,
2005–2012.
https://doi.org/10.1371/journal.pone.0175515.g001
Fig 2. Hazard ratios for total mortality and marital status plus neighborhood socioeconomic status
(SES), California, 2005–2012. Hazard ratios estimated from Cox proportional hazard models adjusted for:
age at diagnosis (continuous), race/ethnicity, subtype (for analysis of all patients), lymph node involvement,
tumor size, grade, histological subtypes, first course of treatment, insurance status; AJCC stage I-IV or
unknown is included as a stratifying variable. High SES group includes neighborhood SES quintiles 4–5 and
low SES group includes quintiles 1–3. Numbers represent hazard ratio and bars represent 95% confidence
interval for each group. *Denotes statistical significance, whereby the confidence intervals do not include 1.
Abbreviations: MRR = hormone receptor; HER2 = human epidermal receptor 2; Ref = reference group.
https://doi.org/10.1371/journal.pone.0175515.g002
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as well as the effect of marital status on mortality by race/ethnicity are sparse, as prior studies
have lacked sufficient sample size to evaluate these associations. Our prior research showed
higher mortality rates among foreign-born relative to US-born APIs with breast cancer, but
lower mortality among foreign-born relative to US-born Hispanics [27, 28]. The smaller effects
for marital status on mortality among foreign-born API patients and lack of marriage effect
among foreign-born Hispanics in the current study may contribute to the understanding of
factors underlying the survival differences between immigrants and their US-born counter-
parts, which merits further study. Specifically, API immigrant breast cancer patients may face
more extreme burdens, such as language barriers, cultural beliefs, and immigration-associated
stress, that limit their ability to benefit from quality access to care and receipt of guideline
treatments; these ethnic- and culturally-specific factors may diminish the potentially beneficial
effects of marriage. On the other hand, immigrant Hispanic breast cancer patients may have
already strong social ties and support from their co-ethnic social networks, that any additional
benefits of marriage may be minimal [29].
We know of no published reports where the association of marital status and mortality
in breast cancer patients has been assessed according to tumor subtype. Given that breast
cancer is considered a heterogeneous disease, this is an important consideration. Indeed,
results of our study showed significant heterogeneity by tumor subtype, with highest associa-
tion observed in HR+/HER2- and lowest in triple negative tumors. Triple negative breast can-
cer is known to be an aggressive subtype with poor prognosis and few treatment options [16].
The beneficial effects of marriage seen in other tumor subtypes with longer life expectancy
may not be as relevant in aggressive and rapidly-progressing tumors characterized by few
treatment options. This is consistent with our prior report [3], where MRRs for total mortality
and marital status were stronger in cancers with better prognosis, including prostate and non-
Hodgkin lymphoma.
Published data on the positive associations between being married and undergoing mam-
mography screening [30] and with breast cancer treatment uptake [31, 32] may explain some
of the associations between marital status and mortality following breast cancer diagnosis,
although the beneficial effect of marriage on breast cancer survival persists after accounting for
treatment [6]. Two main pathways have been proposed to explain the benefits of marital status
on cancer and overall longevity [33]: better economic resources and greater social support.
In regard to the first pathway, we previously assessed the effect of nSES and health insurance
status on overall survival from the 10 most common cancers [3]. Our results suggested that
the higher mortality associated with being unmarried vs. married was not explained by the
availability of financial resources [34]. MRRs unadjusted for nSES and health insurance were
1.27 for males and 1.19 for females and attenuated slightly to 1.22 and 1.15, respectively, after
adjustment for these two economic-related variables. In fact, the significant interaction seen in
the analysis of the cross-classification of marital status and nSES in this report suggests that the
lack of neighborhood resources may compound, rather than explain, the effect of unmarried
status on outcomes. Marital ties increase social network size not just through availability of a
partner but through access to the partner’s network ties, while nSES may reflect social capital
as well as proxy of individual-level SES. Significant additive and interactive effects seen in
these analyses suggest that both high SES neighborhoods and marital ties each confer different
and critical resources predictive of survival.
Relative to the social support pathway, prior research shows better breast cancer survival
among patients with a larger number of social ties [2, 35–37] and with greater social support
[38, 39]. However, data on these specific contextual factors and whether they mediate or moder-
ate the marital status association are not known. Women’s social relationships have been shown
to influence choice of mastectomy or lumpectomy [40], whether to pursue chemotherapy [41],
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and other treatment decisions [41]. A marital partner may also provide critical support that
helps improve health behaviors. In a recent study, women with breast cancer who were unmar-
ried were more likely to be current smokers and less likely to receive chemotherapy [42]. Cluze
et al. [43] also reported that a larger number of family members or friends supporting the breast
cancer patient was associated with better adherence to adjuvant endocrine therapy. Clinical
implications of these and our current results are evident, including awareness among oncolo-
gists and other cancer providers to recognize unmarried patients as a high-risk group for higher
mortality. Consequently, it may be beneficial to involve nurse case managers, clinical social
workers and/or psychologists at various points during a patient’s prolonged treatment course.
For the research community, it is important to note that data on social factors and social sup-
port as an explanatory factor for the reported association between marital status and mortality
in cancer patients are limited, requiring much needed work focused on exploring possible
mechanisms to guide future interventions. Biologic mechanisms potentially responsible for
poor social support and isolation associated with breast cancer progression include immune,
endocrine function, and stress-related factors [44], variables that have been linked with tumor
growth and progression in breast cancer animal models and human studies [45–47].
Results of our study must be interpreted in light of the limitations. Although it could be
argued that assessing marital status at time of diagnosis is appropriate in terms of timing, we
could not assess changes in marital status following a breast cancer diagnosis. It is also impor-
tant to note that we lacked information on co-habitation, support from children and other
family members, and quality of marriage. Cancer registry-recorded race, ethnicity, and birth-
place may be subject to some misclassification; however, because this information is usually
based on self-report (extracted from patient medical records) [48], it is generally accurate
for most racial/ethnic groups [10, 11, 49–51]. However, because registry birthplace data are
incomplete in a biased manner, we used a validated approach to impute nativity. Further, we
lacked information on comorbidities, specific treatment modalities, which could be potential
mediators or confounders in our analyses. Specifically, we do not have data on psychological
and cultural factors, or levels of social support. As a result, we are not able to address specific
contextual factors responsible for the observed associations between marital status and mortal-
ity. Our results may not be generalizable beyond the California population. We cannot dismiss
the possibility of self-selection, whereby women who are physically, emotionally, or psycholog-
ically healthier may be more likely to marry than those who are not. In addition, selection out
of marriage due to divorce might also contribute to this self-selection.
Our results show that breast cancer patients who are unmarried have higher all-cause mor-
tality compared to married patients, but that this survival benefit varies across racial/ethnic
groups, by tumor subtype, and nSES. These findings along with the growing body of evidence
on this topic underscore the importance of identifying and examining the reasons for the gap
in mortality in married versus unmarried patients. These data are urgently needed so that we
can identify and implement targeted interventions that could help ameliorate the poorer sur-
vival among unmarried breast cancer patients.
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S1 Table. Adjusted hazard ratios (MRR) and 95% confidence intervals (CIs) for total mor-
tality associated with marital status plus neighborhood socioeconomic status (SES), Cali-
fornia, 2005–2012. Abbreviations: HR = hormone receptor; HER2 = human epidermal
receptor 2; Q = quintile.
aEstimated from Cox proportional hazard models adjusted for: age at diagnosis (continuous),
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